Kanabo Group (LON:KNB) Shares Down 13.1% – Here’s Why

Kanabo Group Plc (LON:KNB)’s stock price traded down 13.1% during mid-day trading on Thursday . The company traded as low as GBX 0.80 ($0.01) and last traded at GBX 0.83 ($0.01). 81,721 shares changed hands during trading, a decline of 76% from the average session volume of 341,156 shares. The stock had previously closed at GBX 0.95 ($0.01).

Kanabo Group Price Performance

The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.49. The firm has a market cap of £5.22 million, a price-to-earnings ratio of -82.60 and a beta of 3.04. The company’s 50-day moving average price is GBX 0.88 and its 200-day moving average price is GBX 1.07.

Kanabo Group Company Profile

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers.

Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment.